These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 31541678

  • 1. Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4/NLRP3 inflammasome pathway in diabetic rats.
    Li XX, Ling SK, Hu MY, Ma Y, Li Y, Huang PL.
    Free Radic Biol Med; 2019 Dec; 145():175-186. PubMed ID: 31541678
    [Abstract] [Full Text] [Related]

  • 2. Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes.
    Lv ZH, Phuong TA, Jin SJ, Li XX, Xu M.
    Oncotarget; 2017 Oct 31; 8(53):91291-91305. PubMed ID: 29207644
    [Abstract] [Full Text] [Related]

  • 3. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
    Chen Y, Wang L, Pitzer AL, Li X, Li PL, Zhang Y.
    J Mol Med (Berl); 2016 Dec 31; 94(12):1335-1347. PubMed ID: 27783111
    [Abstract] [Full Text] [Related]

  • 4. Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway.
    Lian D, Yuan H, Yin X, Wu Y, He R, Huang Y, Chen Y.
    Phytomedicine; 2019 Mar 01; 55():310-319. PubMed ID: 30385134
    [Abstract] [Full Text] [Related]

  • 5. Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET-1/Nox4 signal pathway in diabetic rats.
    Su J, An XR, Li Q, Li XX, Cong XD, Xu M.
    Sci Rep; 2018 Aug 22; 8(1):12620. PubMed ID: 30135489
    [Abstract] [Full Text] [Related]

  • 6. Argirein alleviates vascular endothelial insulin resistance through suppressing the activation of Nox4-dependent O2- production in diabetic rats.
    Li Q, Su J, Jin SJ, Wei W, Cong XD, Li XX, Xu M.
    Free Radic Biol Med; 2018 Jun 22; 121():169-179. PubMed ID: 29709706
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1.
    Chen Y, Pitzer AL, Li X, Li PL, Wang L, Zhang Y.
    J Cell Mol Med; 2015 Dec 22; 19(12):2715-27. PubMed ID: 26293846
    [Abstract] [Full Text] [Related]

  • 9. The protective effects of orexin a against high glucose-induced activation of NLRP3 inflammasome in human vascular endothelial cells.
    Zhang C, Abdukerim M, Abilailieti M, Tang L, Ling Y, Pan S.
    Arch Biochem Biophys; 2019 Sep 15; 672():108052. PubMed ID: 31351069
    [Abstract] [Full Text] [Related]

  • 10. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W, Zhao M, Zhao S, Lu Q, Ni L, Zou C, Lu L, Xu X, Guan H, Zheng Z, Qiu Q.
    Inflamm Res; 2017 Feb 15; 66(2):157-166. PubMed ID: 27785530
    [Abstract] [Full Text] [Related]

  • 11. Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway.
    Bao X, Li J, Ren C, Wei J, Lu X, Wang X, Du W, Jin X, Ma B, Zhang Q, Ma B.
    Chem Biol Interact; 2022 Sep 25; 365():110074. PubMed ID: 35961541
    [Abstract] [Full Text] [Related]

  • 12. A novel mechanism of diabetic vascular endothelial dysfunction: Hypoadiponectinemia-induced NLRP3 inflammasome activation.
    Zhang J, Xia L, Zhang F, Zhu D, Xin C, Wang H, Zhang F, Guo X, Lee Y, Zhang L, Wang S, Guo X, Huang C, Gao F, Liu Y, Tao L.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun 25; 1863(6):1556-1567. PubMed ID: 28216285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Favorable effect of rivaroxaban against vascular dysfunction in diabetic mice by inhibiting NLRP3 inflammasome activation.
    Li Q, Yang XT, Wei W, Hu XP, Li XX, Xu M.
    J Cell Physiol; 2022 Aug 25; 237(8):3369-3380. PubMed ID: 35675485
    [Abstract] [Full Text] [Related]

  • 16. Contribution of cathepsin B-dependent Nlrp3 inflammasome activation to nicotine-induced endothelial barrier dysfunction.
    Zhang Y, Chen Y, Zhang Y, Li PL, Li X.
    Eur J Pharmacol; 2019 Dec 15; 865():172795. PubMed ID: 31733211
    [Abstract] [Full Text] [Related]

  • 17. Vildagliptin inhibits high free fatty acid (FFA)-induced NLRP3 inflammasome activation in endothelial cells.
    Qi Y, Du X, Yao X, Zhao Y.
    Artif Cells Nanomed Biotechnol; 2019 Dec 15; 47(1):1067-1074. PubMed ID: 30945564
    [Abstract] [Full Text] [Related]

  • 18. Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation.
    Luo X, Hu Y, He S, Ye Q, Lv Z, Liu J, Chen X.
    Arch Biochem Biophys; 2019 Aug 15; 671():203-209. PubMed ID: 31302140
    [Abstract] [Full Text] [Related]

  • 19. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.
    Boini KM, Hussain T, Li PL, Koka S.
    Cell Physiol Biochem; 2017 Aug 15; 44(1):152-162. PubMed ID: 29130962
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation.
    Wang L, Chen Y, Li X, Zhang Y, Gulbins E, Zhang Y.
    Oncotarget; 2016 Nov 08; 7(45):73229-73241. PubMed ID: 27689324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.